Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The investigators test the renal and cardiovascular protective effects dextromethorphan and silymarin on patients with the proteinuric chronic kidney diseases, who enrolled in our clinical trial, had progressing kidney diseases and merit aggressive anti-inflammatory therapy.
Epistemonikos ID: 0ea9816cd01b28a09fd50d7f3d2ab1cc94f209e3
First added on: May 05, 2024